Keudell Gilead Sciences, Inc. Transaction History

Keudell

$366 Million
Q3 2024

A detailed history of Keudell transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Keudell holds 8,757 shares of GILD stock, worth $810,723. This represents 0.2% of its overall portfolio holdings.

Number of Shares

8,757

Previous 8,864 1.21%

Holding current value

$810,723

Previous $608,000 20.72%

% of portfolio

0.2%

Previous 0.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$66.59 - $83.99 $7,125 - $8,986	-107 Reduced 1.21%	8,757 $734,000
Q2 2024 Jul 16, 2024	BUY	$63.15 - $72.88 $757 - $874	12 Added 0.14%	8,864 $608,000
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $128,414 - $156,598	1,794 Added 25.42%	8,852 $648,000
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $48,284 - $54,756	-659 Reduced 8.54%	7,058 $571,000
Q3 2023 Oct 18, 2023	BUY	$73.94 - $80.67 $49,096 - $53,564	664 Added 9.41%	7,717 $578,000
Q2 2023 Jul 20, 2023	SELL	$76.01 - $86.7 $103,297 - $117,825	-1,359 Reduced 16.16%	7,053 $543,000
Q1 2023 Apr 18, 2023	SELL	$77.31 - $88.08 $280,016 - $319,025	-3,622 Reduced 30.1%	8,412 $697,000
Q4 2022 Jan 20, 2023	SELL	$62.32 - $89.47 $98,278 - $141,094	-1,577 Reduced 11.59%	12,034 $0
Q3 2022 Oct 12, 2022	BUY	$59.54 - $68.01 $11,014 - $12,581	185 Added 1.38%	13,611 $840,000
Q2 2022 Jul 18, 2022	BUY	$57.72 - $65.01 $89,985 - $101,350	1,559 Added 13.14%	13,426 $830,000
Q1 2022 Apr 18, 2022	BUY	$57.92 - $72.58 $141,035 - $176,732	2,435 Added 25.82%	11,867 $705,000
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $84,019 - $95,363	-1,295 Reduced 12.07%	9,432 $685,000
Q3 2021 Oct 20, 2021	BUY	$67.69 - $73.03 $31,002 - $33,447	458 Added 4.46%	10,727 $749,000
Q2 2021 Jul 13, 2021	BUY	$63.47 - $69.35 $13,963 - $15,256	220 Added 2.19%	10,269 $707,000
Q1 2021 Apr 13, 2021	BUY	$60.0 - $68.46 $60,420 - $68,939	1,007 Added 11.14%	10,049 $649,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $78,177 - $89,079	1,380 Added 18.01%	9,042 $527,000
Q3 2020 Oct 20, 2020	BUY	$62.1 - $78.08 $193,317 - $243,063	3,113 Added 68.43%	7,662 $484,000
Q2 2020 Jul 14, 2020	SELL	$72.34 - $84.0 $304,045 - $353,052	-4,203 Reduced 48.02%	4,549 $350,000
Q1 2020 Apr 20, 2020	BUY	$62.63 - $80.22 $7,515 - $9,626	120 Added 1.39%	8,752 $654,000
Q4 2019 Jan 29, 2020	BUY	$61.62 - $67.78 $54,718 - $60,188	888 Added 11.47%	8,632 $561,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $135,771 - $149,868	2,172 Added 38.98%	7,744 $491,000
Q2 2019 Aug 23, 2019	BUY	$61.87 - $69.38 $344,739 - $386,585	5,572 New	5,572 $356,000
Q2 2019 Aug 21, 2019	SELL	$61.87 - $69.38 $190,807 - $213,967	-3,084 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$62.53 - $70.05 $192,842 - $216,034	3,084 New	3,084 $200,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account